What is the company's size? (Annual sales and employees)
Hematology & Oncology Associates of Northeastern PA's annual revenues are $10 - $100 million (see exact revenue data)
What industry is the company in?
Hematology & Oncology Associates of Northeastern PA is classified as operating in the Physicians, Mental Health Specialists industry, NAICS Code 621112.
Hematology & Oncology Associates of Northeastern PA Annual Revenue and Growth Rate
Hematology & Oncology Associates of Northeastern PA
Note: Hematology & Oncology Associates of Northeastern PA's revenues are gauged from an analysis of company filings.
Hematology & Oncology Associates of Northeastern PA's Income Statement (based on Industry Averages)
Hematology & Oncology Associates of Northeastern PA P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Market Share of Hematology & Oncology Associates of Northeastern PA's Largest Competitors
A competitive analysis shows these companies are in the same general field as Hematology & Oncology Associates of Northeastern PA, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Hematology & Oncology Associates of Northeastern PA.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Hematology & Oncology Associates of Northeastern PA and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.